As a member of Mayo Clinic's Myeloma, Amyloidosis, Dysproteinemia Group, Martha Q. Lacy, M.D., conducts research in developing new therapeutics for the treatment of plasma cell disorders. Dr. Lacy's clinical research centers on immunotherapy, stem cell transplant and novel agents to optimize treatment for multiple myeloma, amyloidosis, Waldenstrom's macroglobulinemia and monoclonal gammopathy. She performs clinical trials and collaborates with scientists on translational research to improve outcomes for patients with these disorders.
Mayo Clinic Rochester:
Gonda Building, 200 1st St SW, Rochester, MN 55905, USA
Get the latest thought leadership on Myeloma delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life
Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma
Thanks to our HealthTree Community for Myeloma Sponsors: